Research ArticleArticle
Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — An Audit Report
ANAND N. MALAVIYA, SANJIV KAPOOR, SHRIRAM GARG, ROOPA RAWAT, SUBRAMANIAN SHANKAR, SAVITA NAGPAL, DINESH KHANNA and DANIEL E. FURST
The Journal of Rheumatology July 2009, 36 (7) 1414-1420; DOI: https://doi.org/10.3899/jrheum.081042
ANAND N. MALAVIYA
SANJIV KAPOOR
SHRIRAM GARG
ROOPA RAWAT
SUBRAMANIAN SHANKAR
SAVITA NAGPAL
DINESH KHANNA
REFERENCES
- 1.↵
- 2.↵
- Wallis RS,
- Broder M,
- Wong J,
- Beenhouwer D
- 3.↵
- Brassard P,
- Kezouh A,
- Suissa S
- 4.↵
- 5.↵Report of the Meeting of the Expert Committee to Estimate TB Burden in India, 10–11th March 2005, New Delhi. [Internet. Accessed March 16, 2009.] Available from: http://www.tbcindia.org/Pdfs/TB%20burden%20consensus.pdf
- 6.↵
- Pathak SK,
- Deshmukh PA,
- Menon CRN
- 7.
- Hardas UD,
- Jayaram VS
- 8.↵
- Paramasivan CN,
- Herbert D,
- Prabhakar R
- 9.↵
- Grover R,
- Kapoor S,
- Marwaha V,
- Malaviya AN,
- Gupta R,
- Kumar A
- 10.↵
- 11.↵
- 12.↵A joint statement. Targeted tuberculin testing and treatment of latent tuberculosis infection. Official statement of the American Thoracic Society (ATS), July 1999; A joint statement of ATS and the Centers for Disease Control and Prevention (CDC); Endorsed by the Council of the Infectious Diseases Society of America (IDSA), September 1999. Am J Respir Crit Care Med 2000;161:S221–S247.
- 13.↵
- 14.↵
- 15.↵
- Spyridis NP,
- Spyridis PG,
- Gelesme A,
- et al
- 16.↵
- 17.↵
- Chaturvedi V,
- Singal V,
- Marwaha V,
- et al
- 18.↵
- Malaviya AN,
- Kapoor S,
- Garg S,
- Ahmad I,
- Raja RR
- 19.↵
- 20.↵
- Huebner RE,
- Schein MF,
- Bass JB, Jr
- 21.↵
- 22.
- Ponce dL,
- Acevedo-Vasquez E,
- Sanchez-Torres A,
- et al
- 23.
- 24.
- Markusse HM,
- Hazes JM,
- Dijkmans BA,
- de Vries RR,
- Stanford JL
- 25.↵
- Matulis G,
- Juni P,
- Villiger PM,
- Gadola SD
- 26.↵
- de Leon DP,
- Vasquez AE,
- Alvizuri S,
- et al
- 27.↵
- 28.↵CDC – Division of Tuberculosis Elimination (DTBE) Fact Sheets; April 2006. [Internet. Accessed March 16, 2009.] Available from: http://www.cdc.gov/tb/pubs/tbfactsheets/BCG.htm.
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- Tissot F,
- Zanetti G,
- Francioli P,
- Zellweger JP,
- Zysset F
- 33.↵
- 34.
- 35.↵
- 36.↵Food and Drug Administration, Center for Devices and Radiological Health. Summary of safety and effectiveness data. QuantiFERON-TB. PMA no. P010033. Rockville, MD: Food and Drug Administration; 2002. [Internet. Accessed March 19, 2009.] Available from: http://www.fda.gov/cdrh/pdf/P010033b.pdf
- 37.↵
- Greenberg JD,
- Reddy SM,
- Schloss SG,
- et al
- 38.↵
- Chen D-Y,
- Shen G-H,
- Hsieh T-Y,
- Hsieh C-W,
- Lanan J-L
- 39.↵
- 40.↵
- National Collaborating Centre for Chronic Diseases
- 41.↵
- Canadian Tuberculosis Committee
In this issue
The Journal of Rheumatology
Vol. 36, Issue 7
1 Jul 2009
Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — An Audit Report
ANAND N. MALAVIYA, SANJIV KAPOOR, SHRIRAM GARG, ROOPA RAWAT, SUBRAMANIAN SHANKAR, SAVITA NAGPAL, DINESH KHANNA, DANIEL E. FURST
The Journal of Rheumatology Jul 2009, 36 (7) 1414-1420; DOI: 10.3899/jrheum.081042
Preventing Tuberculosis Flare in Patients with Inflammatory Rheumatic Diseases Receiving Tumor Necrosis Factor-α Inhibitors in India — An Audit Report
ANAND N. MALAVIYA, SANJIV KAPOOR, SHRIRAM GARG, ROOPA RAWAT, SUBRAMANIAN SHANKAR, SAVITA NAGPAL, DINESH KHANNA, DANIEL E. FURST
The Journal of Rheumatology Jul 2009, 36 (7) 1414-1420; DOI: 10.3899/jrheum.081042